APA (7th ed.) Citation

Lübbert, M., Suciu, S., Hagemeijer, A., Rüter, B., Platzbecker, U., Giagounidis, A., . . . Helm, L. (2016). Decitabine improves progression-free survival in older high-risk MDS patients with multiple autosomal monosomies: Results of a subgroup analysis of the randomized phase III study 06011 of the EORTC Leukemia Cooperative Group and German MDS Study Group. Annals of Hematology, 95(2), 191. https://doi.org/10.1007/s00277-015-2547-0

Chicago Style (17th ed.) Citation

Lübbert, Michael, et al. "Decitabine Improves Progression-free Survival in Older High-risk MDS Patients with Multiple Autosomal Monosomies: Results of a Subgroup Analysis of the Randomized Phase III Study 06011 of the EORTC Leukemia Cooperative Group and German MDS Study Group." Annals of Hematology 95, no. 2 (2016): 191. https://doi.org/10.1007/s00277-015-2547-0.

MLA (9th ed.) Citation

Lübbert, Michael, et al. "Decitabine Improves Progression-free Survival in Older High-risk MDS Patients with Multiple Autosomal Monosomies: Results of a Subgroup Analysis of the Randomized Phase III Study 06011 of the EORTC Leukemia Cooperative Group and German MDS Study Group." Annals of Hematology, vol. 95, no. 2, 2016, p. 191, https://doi.org/10.1007/s00277-015-2547-0.